Identification of a Nonribosomal Peptide Analog With Activity Against Multiple Gram‐Positive Bacteria via a Synthetic Bioinformatic Natural Product Discovery Approach
Advanced Science · 2026
DOI: 10.1002/advs.76103 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Keyi Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Gram-Positive Bacteria, Biological Products, Computational Biology, Anti-Bacterial Agents. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Zhejiang Provincial Natural Science Foundation of China.
Abstract (Originalsprache)
Nonribosomal peptide (NRP) antibiotics exhibit potent biological activities and are broadly used in clinical therapy. Because most microorganisms are difficult to culture and many antibiotic biosynthetic genes are silent, traditional activity tracking approaches face major limitations in the discovery of novel NRPs. Here, based on a synthetic bioinformatic natural product (syn‐BNP) discovery approach that integrates bioinformatics and chemical synthesis, a novel nonribosomal peptide synthetase (NRPS) gene cluster from the genome of Rhodococcus erythropolis D‐1 was mined. A putative NRP scaffold synthesized by the NRPS encoded by this cluster was predicted. Through chemical synthesis and four rounds of structure‐activity relationship (SAR) studies, 37 NRP analogs were ultimately generated. Among these analogs, ZURJC28 shows activity against multiple Gram‐positive bacteria, including two drug‐resistant strains. Mechanistic studies and metabolomics analyses revealed that ZURJC28 exerts membrane‐disruptive activity associated with interaction with phosphatidylglycerol (PG)‐enriched Gram‐positive membranes, leading to membrane damage and widespread metabolic dysregulation. ZURJC28 also shows low cytotoxicity and low hemolytic activity, suggesting its preliminary in vitro safety profile.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Biochemistry, College of Life Sciences, Zhejiang University, Hangzhou, China.
- Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China.
- ZJU-UoE Joint Research Centre for Engineering Biology, International Campus of Zhejiang University, Zhejiang University, Haining, China.
- Zhejiang University-Lishui Joint Innovation Center for Life and Health & Lishui Lvgu Institute for Life and Health, Lishui, China.
ORCID-Profile: Hui Jiang
Förderung
- Zhejiang Provincial Natural Science Foundation of China
Zitieren
APA
Chen, K., Liang, J., Wu, Y., Xu, J., Liu, Y., Wang, W., Jiang, X., Gao, B., Wang, Y., & Jiang, H. (2026). Identification of a Nonribosomal Peptide Analog With Activity Against Multiple Gram‐Positive Bacteria via a Synthetic Bioinformatic Natural Product Discovery Approach. Advanced Science. https://doi.org/10.1002/advs.76103
Vancouver
Chen K, Liang J, Wu Y, Xu J, Liu Y, Wang W, et al. Identification of a Nonribosomal Peptide Analog With Activity Against Multiple Gram‐Positive Bacteria via a Synthetic Bioinformatic Natural Product Discovery Approach. Advanced Science. 2026. doi:10.1002/advs.76103
BibTeX
@article{Chen2026,
author = {Chen, Keyi and Liang, Jiayi and Wu, Yujia and Xu, Jianan and Liu, Yi and Wang, Wenguang and Jiang, Xinhang and Gao, Benjie and Wang, Yueyue and Jiang, Hui},
title = {Identification of a Nonribosomal Peptide Analog With Activity Against Multiple Gram‐Positive Bacteria via a Synthetic Bioinformatic Natural Product Discovery Approach},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.76103}
}
EUVIMED